Dr. Kyriakos Papadopoulos, MD
Claim this profileSouth Texas Accelerated Research Therapeutics
Studies Solid Tumors
Studies Tumors
7 reported clinical trials
10 drugs studied
Area of expertise
1Solid Tumors
Stage IV
Beta-catenin positive
APC positive
2Tumors
Stage IV
Beta-catenin positive
APC positive
Affiliated Hospitals
Clinical Trials Kyriakos Papadopoulos, MD is currently running
KZR-261
for Cancer
This trial is testing a new drug called KZR-261 to see if it is safe and effective for patients with advanced cancers that haven't responded to other treatments. The study will look at how the drug moves through the body and its effects on tumors.
Recruiting1 award Phase 1
PM54
for Solid Tumors
This trial is testing a new drug called PM54 to see if it is safe and effective in shrinking tumors and keeping them stable for several months in patients with advanced cancer.
Recruiting1 award Phase 1
More about Kyriakos Papadopoulos, MD
Clinical Trial Related2 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 6 Active Clinical TrialsTreatments Kyriakos Papadopoulos, MD has experience with
- FS120
- XMT-2056
- FOG-001
- PM54
- SY-5609
- Fulvestrant
Breakdown of trials Kyriakos Papadopoulos, MD has run
Solid Tumors
Breast Cancer
Non-Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Kyriakos Papadopoulos, MD specialize in?
Kyriakos Papadopoulos, MD focuses on Solid Tumors and Tumors. In particular, much of their work with Solid Tumors has involved Stage IV patients, or patients who are Beta-catenin positive.
Is Kyriakos Papadopoulos, MD currently recruiting for clinical trials?
Yes, Kyriakos Papadopoulos, MD is currently recruiting for 6 clinical trials in San Antonio Texas. If you're interested in participating, you should apply.
Are there any treatments that Kyriakos Papadopoulos, MD has studied deeply?
Yes, Kyriakos Papadopoulos, MD has studied treatments such as FS120, XMT-2056, FOG-001.
What is the best way to schedule an appointment with Kyriakos Papadopoulos, MD?
Apply for one of the trials that Kyriakos Papadopoulos, MD is conducting.
What is the office address of Kyriakos Papadopoulos, MD?
The office of Kyriakos Papadopoulos, MD is located at: South Texas Accelerated Research Therapeutics, San Antonio, Texas 78229-3307 United States. This is the address for their practice at the South Texas Accelerated Research Therapeutics.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.